Get started
Author

Yingwei Qi

A Phase II Study of AT-101 (Gossypol) in Chemotherapy-Sensitive Recurrent Extensive-Stage Small Cell Lung Cancer
2011 · Maria Q. Baggstrom, Yingwei Qi, et al. · Journal of Thoracic Oncology · 161
Natural History of Pelvic Organ Prolapse in Postmenopausal Women
2007 · Catherine S. Bradley, M Bridget Zimmerman, et al. · Obstetrics and Gynecology · 159
Tumor response and progression‐free survival as potential surrogate endpoints for overall survival in extensive stage small‐cell lung cancer
2010 · Nathan R. Foster, Yingwei Qi, et al. · Cancer · 110
PDF
Effect of cigarette smoking on quality of life in small cell lung cancer patients
2012 · Jun Chen, Yingwei Qi, et al. · European Journal of Cancer · 78
PDF
Pretreatment Quality of Life Is an Independent Prognostic Factor for Overall Survival in Patients with Advanced Stage Non-small Cell Lung Cancer
2009 · Yingwei Qi, Steven E. Schild, et al. · Journal of Thoracic Oncology · 62
Phase I dose escalation study of the PKCι inhibitor aurothiomalate for advanced non-small-cell lung cancer, ovarian cancer, and pancreatic cancer
2013 · Aaron S. Mansfield, Alan P. Fields, et al. · Anti-Cancer Drugs · 59
Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid tumors
2014 · Brian A. Costello, Mitesh J. Borad, et al. · Investigational New Drugs · 57
Endpoints in Phase II Trials for Advanced Non-small Cell Lung Cancer
2010 · Sumithra J. Mandrekar, Yingwei Qi, et al. · Journal of Thoracic Oncology · 38
Phase I study of temsirolimus in combination with EKB-569 in patients with advanced solid tumors
2011 · Alan H. Bryce, Ravi Rao, et al. · Investigational New Drugs · 33
Alpha1-Antitrypsin Deficiency Carriers, Serum Alpha 1-Antitrypsin Concentration, and Non-small Cell Lung Cancer Survival
2010 · Yan Li, Michael J. Krowka, et al. · Journal of Thoracic Oncology · 27
Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer
2019 · Angela L. McCleary-Wheeler, Ryan M. Carr, et al. · Pancreatology · 23
The cancer anorexia/weight loss syndrome: exploring associations with single nucleotide polymorphisms (SNPs) of inflammatory cytokines in patients with non-small cell lung cancer
2009 · Aminah Jatoi, Yingwei Qi, et al. · Supportive Care in Cancer · 21
Impact of disease progression date determination on progression‐free survival estimates in advanced lung cancer
2012 · Yingwei Qi, Katie L. Allen Ziegler, et al. · Cancer · 17
A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumors
2020 · Mojun Zhu, Julian R. Molina, et al. · Investigational New Drugs · 16
A phase I study of once-weekly aminoflavone prodrug (AFP464) in solid tumor patients.
2011 · M. P. Goetz, J. M. Reid, et al. · Journal of Clinical Oncology · 16
Phase I trial erlotinib, gemcitabine, and the hedgehog inhibitor, GDC-0449.
2011 · S. R. Palmer, C. Erlichman, et al. · Journal of Clinical Oncology · 11
NCCTG N0821 (Alliance): A Phase II First-Line Study of Pemetrexed, Carboplatin, and Bevacizumab in Elderly Patients with Advanced Nonsquamous Non–Small-Cell Lung Cancer With Good Performance Status
2014 · Grace K. Dy, Julian R. Molina, et al. · Journal of Thoracic Oncology · 6
N0821: A phase II first-line study of a combination of pemetrexed (P), carboplatin (C), and bevacizumab (B) in elderly patients with good performance status (PS < 2).
2012 · Grace K. Dy, Julian R. Molina, et al. · Journal of Clinical Oncology · 4
Baseline quality of life (QOL) as a prognostic factor for overall survival (OS) in patients (Pts) with advanced stage non-small cell lung cancer (A-NSCLC): An analysis of NCCTG studies
2008 · S. E. Schild, Y. Qi, et al. · Journal of Clinical Oncology · 4
Phase II trial of R-(-)-gossypol acetic acid (NSC 726190, AT-101) in patients with recurrent extensive stage small cell lung cancer (ES-SCLC).
2010 · M. Q. Baggstrom, R. Govindan, et al. · Journal of Clinical Oncology · 3
Phase I dose escalation study of the protein kinase C iota inhibitor aurothiomalate for advanced non-small cell lung cancer, ovarian cancer, and pancreatic cancer.
2013 · Aaron Scott Mansfield, Alan P. Fields, et al. · Journal of Clinical Oncology · 2
The Purported Effects of Alcohol on Appetite and Weight in Lung Cancer Patients
2011 · Aminah Jatoi, Yingwei Qi, et al. · Nutrition and Cancer · 2
Impact of disease progression (DP) date determination method on post progression survival (PPS) and DP metrics in advanced lung cancer.
2012 · Sumithra J. Mandrekar, Nathan R. Foster, et al. · Journal of Clinical Oncology · 1
Phase I trial of everolimus, gemcitabine and cisplatin for patients with solid tumors refractory to standard therapy.
2012 · Brian Addis Costello, Yingwei Qi, et al. · Journal of Clinical Oncology · 1
WITHDRAWN: 1086P Clinical significance of cardiophrenic lymph node enlargement and resection in advanced epithelial ovarian cancers: A cohort study
2025 · Q. Wu, H. Wang, et al. · Annals of Oncology
Works count: 26
Citation count: 911
H-index: 15
I10-index: 16
Year
Topic
Type